87.48MMarket Cap
LossP/E TTM
Oncolytics Biotech Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Oncolytics Biotech Inc is 7.92, ranking 135 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.32, which is -48.60% below the recent high of -1.19 and -321.55% above the recent low of -9.77.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.